Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
57.05
-0.06 (-0.11%)
Nov 8, 2024, 4:00 PM EST - Market closed
Soleno Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 48.41 | 169.68 | 14.6 | 21.3 | 49.22 | 20.73 | Upgrade
|
| Short-Term Investments | 208.36 | - | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 256.78 | 169.68 | 14.6 | 21.3 | 49.22 | 20.73 | Upgrade
|
| Cash Growth | 389.68% | 1062.04% | -31.46% | -56.72% | 137.42% | -13.89% | Upgrade
|
| Prepaid Expenses | 1.42 | 1.68 | 1.05 | 1.12 | 1.02 | 0.41 | Upgrade
|
| Total Current Assets | 258.2 | 171.36 | 15.65 | 22.42 | 50.24 | 21.14 | Upgrade
|
| Property, Plant & Equipment | 3.19 | 0.42 | 0.16 | 0.45 | 0.16 | 0.44 | Upgrade
|
| Other Intangible Assets | 7.29 | 8.75 | 10.69 | 12.64 | 14.58 | 16.53 | Upgrade
|
| Other Long-Term Assets | 0.08 | 0.17 | - | 0.04 | - | 0.06 | Upgrade
|
| Total Assets | 296.71 | 180.69 | 26.5 | 35.55 | 64.98 | 38.17 | Upgrade
|
| Accounts Payable | 6.24 | 3.15 | 1.78 | 3.25 | 3.49 | 2 | Upgrade
|
| Accrued Expenses | 5.17 | 6.53 | 4.9 | 4.15 | 4.79 | 2.28 | Upgrade
|
| Current Portion of Leases | 0.45 | 0.27 | 0.16 | 0.28 | 0.15 | 0.32 | Upgrade
|
| Other Current Liabilities | 3.1 | 1.56 | 0.48 | 0.32 | 0.19 | 0.37 | Upgrade
|
| Total Current Liabilities | 14.96 | 11.51 | 7.31 | 8.01 | 8.62 | 4.96 | Upgrade
|
| Long-Term Leases | 2.58 | 0.13 | - | 0.18 | - | 0.15 | Upgrade
|
| Other Long-Term Liabilities | 14.46 | 11.55 | 8.84 | 9.58 | 10.82 | 18.11 | Upgrade
|
| Total Liabilities | 32.01 | 23.18 | 16.15 | 17.76 | 19.44 | 23.23 | Upgrade
|
| Common Stock | 0.04 | 0.03 | 0.01 | 0.08 | 0.08 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 660.04 | 433.89 | 247.76 | 231.07 | 227.91 | 172.71 | Upgrade
|
| Retained Earnings | -396.28 | -276.41 | -237.42 | -213.36 | -182.45 | -157.81 | Upgrade
|
| Total Common Equity | 264.7 | 157.51 | 10.35 | 17.79 | 45.55 | 14.95 | Upgrade
|
| Shareholders' Equity | 264.7 | 157.51 | 10.35 | 17.79 | 45.55 | 14.95 | Upgrade
|
| Total Liabilities & Equity | 296.71 | 180.69 | 26.5 | 35.55 | 64.98 | 38.17 | Upgrade
|
| Total Debt | 3.03 | 0.4 | 0.16 | 0.46 | 0.15 | 0.47 | Upgrade
|
| Net Cash (Debt) | 281.69 | 169.28 | 14.45 | 20.85 | 49.08 | 20.26 | Upgrade
|
| Net Cash Growth | 442.06% | 1071.72% | -30.70% | -57.52% | 142.19% | -15.84% | Upgrade
|
| Net Cash Per Share | 7.44 | 10.26 | 1.72 | 3.92 | 11.76 | 8.90 | Upgrade
|
| Filing Date Shares Outstanding | 43.12 | 32.46 | 8.17 | 5.34 | 5.31 | 2.98 | Upgrade
|
| Total Common Shares Outstanding | 41.04 | 31.68 | 8.16 | 5.32 | 5.31 | 2.98 | Upgrade
|
| Working Capital | 243.24 | 159.85 | 8.33 | 14.42 | 41.63 | 16.18 | Upgrade
|
| Book Value Per Share | 6.45 | 4.97 | 1.27 | 3.34 | 8.58 | 5.02 | Upgrade
|
| Tangible Book Value | 257.41 | 148.76 | -0.35 | 5.16 | 30.97 | -1.58 | Upgrade
|
| Tangible Book Value Per Share | 6.27 | 4.70 | -0.04 | 0.97 | 5.83 | -0.53 | Upgrade
|
| Machinery | - | 0.1 | 0.1 | 0.1 | 0.05 | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.